Glutamine reduces the expression of leukocyte integrins leukocyte function-associated antigen-1 and macrophage antigen-1 in mice exposed to arsenic.
Chronic arsenic exposure results in an increased oxidative stress and inflammation in the body. Glutamine (GLN) is an amino acid considered to have immunomodulatory effects and attenuate the inflammatory reaction. This study was designed to examine the effect of GLN supplementation on inflammatory-related leukocyte integrin expression and in vitro splenocyte cytokine production in mice exposed to arsenic. Mice were assigned to the control and experimental groups. The control group drank deionized water, whereas the experimental group drank deionized water containing 50 ppm of sodium arsenite. Each control and experimental group was further divided into 2 subgroups and fed diets for 5 weeks. One subgroup was fed a semipurified diet, whereas the other subgroup was fed a diet where part of the casein was replaced with GLN, which provided 25% of the total amino acid nitrogen. The results showed that plasma GLN levels of mice in the arsenic group were significantly lower than those in the control groups. Glutamine supplementation reversed the depletion of plasma GLN in the arsenic group. beta(2) intergins, including leukocyte function-associated antigen-1 and macrophage antigen-1 expressed by leukocytes, were significantly higher in the arsenic group than the control groups. Glutamine supplementation reduced leukocyte integrin expression in mice exposed to arsenic. There were no differences in interleukin 4, interleukin 6, interferon gamma, and tumor necrosis factor alpha production between the 2 arsenic groups when splenocytes were stimulated with mitogen. These results suggest that arsenic exposure results in depletion of plasma GLN and higher leukocyte integrin expression. Glutamine supplementation normalized the plasma GLN levels and reduced leukocyte leukocyte function-associated antigen-1 and macrophage antigen-1 expression. However, cytokine modulation may not be responsible for reducing leukocyte integrin expression in mice exposed to arsenic.
Pai
Man-Hui
MH
Department of Anatomy, Taipei Medical University, Taipei 110, Taiwan, ROC.
Chien
Yi-Wen
YW
Tsai
Ya-Hui
YH
Hu
Ya-Mei
YM
Yeh
Sung-Ling
SL
D000818:Animals; D001151:Arsenic / Q000008:administration & dosage* / Q000633:toxicity; D002478:Cells, Cultured; D004032:Diet; D005434:Flow Cytometry; D005973:Glutamine / Q000008:administration & dosage* / Q000097:blood; D007962:Leukocytes / Q000737:chemistry; D016169:Lymphocyte Function-Associated Antigen-1 / Q000097:blood*; D016177:Macrophage-1 Antigen / Q000097:blood*; D051379:Mice; D008807:Mice, Inbred BALB C; D013154:Spleen / Q000166:cytology
D016169:Lymphocyte Function-Associated Antigen-1; D016177:Macrophage-1 Antigen; D005973:Glutamine; D001151:Arsenic